Mammakarzinom

AXSANA

Titel: AXSANA: Prospektive, multizentrische Registerstudie zur Bewertung verschiedener leitlinienkonformer Operationsverfahren in der Axilla (Sentinel-Node Biopsie, Targeted Axillary Dissection, Axilladissektion) nach neoadjuvanter Chemotherapie
Ansprechpartner: OÄ Beatrix Janke, Tel. 07131/49-34103
Klinik: Frauenklinik, Klinikum am Gesundbrunnen
Status: offen

Adaptlate

Titel: A randomized, controlled, open-label, phase-III trial on Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing abemaciclib combined with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy in (clinical or genomic) high risk, HR+/HER2- early breast cancer (ADAPTlate)
Ansprechpartner: OÄ Beatrix Janke, Tel. 07131/49-34103
Klinik: Frauenklinik, Klinikum am Gesundbrunnen
Status: offen

PlanB Langzeit-Nachsorgeregister

Titel: Long term follow up registry for outcome evaluation in HR-positive/HER2 negative early breast cancer patients treated within the prospective PlanB study and relapse free after 5 years of endocrine therapy
Ansprechpartner: OÄ Beatrix Janke, Tel. 07131/49-34103
Klinik: Frauenklinik, Klinikum am Gesundbrunnen
Status: offen

Studie ADAPTcycle

Titel: Adjuvant Dynamic marker-Adjusted Personalized Therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate risk HR+/HER2- early breast cancer (ADAPTcycle)
Ansprechpartner: OÄ Beatrix Janke, Tel. 07131/49-34103
Klinik: Frauenklinik, Klinikum am Gesundbrunnen
Status: offen